For instance, acetylation of Microtubule-associated protein tau (Tau) at K280 has been linked with normal brain aging as well as a wide spectrum of human neurodegenerative diseases including Alzheimer's disease (13, 14), suggesting the potential of lysine acetylation as aging biomarkers. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.